Anzeige
❌
Mehr »
Mittwoch, 07.10.2026 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
IB

WKN: 914998 | ISIN: BE0003766806 | Ticker-Symbol: IOB
Tradegate
06.10.26 | 20:29
15,660 Euro
0,00 % 0,000
Branche
Sonstige Technologie
Aktienmarkt
BEL Mid
1-Jahres-Chart
ION BEAM APPLICATIONS SA Chart 1 Jahr
5-Tage-Chart
ION BEAM APPLICATIONS SA 5-Tage-Chart
RealtimeGeldBriefZeit
15,64015,70011:48
15,64015,70011:42

Aktuelle News zur ION BEAM APPLICATIONS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoIBA SA: IBA and Telix strengthen ties through agreement to distribute ARTMS's QIS278IBA to offer QUANTM Irradiation System solid-target technology to cyclotron users worldwide, scaling local production of radiometals for theranostics Louvain-la-Neuve, Belgium - October 1st, 2026...
► Artikel lesen
29.09.IBA SA: IBA signs contract to install the first proton therapy center in central Italy, in Rome273Louvain-La-Neuve, Belgium, September 29, 2026 at 7 a.m. CEST - IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world's leading provider of...
► Artikel lesen
28.09.IBA SA: Penn Medicine and IBA Launch Joint Venture to Advance Proton Therapy and Radiation Oncology Program Development Worldwide229New expert-led services platform will help healthcare providers develop, implement, and optimize proton therapy and advanced radiation oncology programs across the full care delivery lifecycle PHILADELPHIA...
► Artikel lesen
27.09.IBA SA: IBA Launches QUASAR Penta-Guide Performance Phantom3
ION BEAM APPLICATIONS Aktie jetzt für 0€ handeln
25.09.IBA SA: IBA to coordinate LIFEDESTINY, a new European LIFE project to advance sustainable PFAS remediation5
02.09.IBA SA: IBA joins PFAROS European initiative to advance PFAS destruction for healthcare and pharmaceutical applications377Louvain-la-Neuve, Belgium, 2 September 2026, 7 a.m. - IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, today announces its participation in PFAROS...
► Artikel lesen
27.08.IBA H1 2026 slides: proton therapy drives 66% EBIT jump25
27.08.IBA SA: IBA reports Half Year 2026 results, on track with its improved profitability trajectory523Louvain-la-Neuve, Belgium, 27 August 2026, 7 a.m. - IBA (Ion Beam Applications S.A.), today announces its consolidated results for the first half of 2026, with performance on track with FY 2026 guidance...
► Artikel lesen
14.07.IBA SA: IBA - Regulated information36
30.06.IBA SA: The National Proton Therapy Center of Portugal will be equipped with two IBA ProteusONE solutions25
25.06.IBA SA: IBA to install the first proton therapy center in Brazil in Rio de Janeiro1.112Louvain-La-Neuve, Belgium, June 25, 2026 - IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world's leading provider of proton therapy solutions...
► Artikel lesen
17.06.Ion Beam Applications: Aktie legt nach Managementumbau um 7 % zu42
17.06.IBA SA: IBA strengthens its Board with two high-profile appointments and announces the payment date of its dividend24
17.06.IBA SA: IBA strengthens its leadership team to support its growth666Olivier Legrain, CEO of IBA, is appointed Vice-Chairman of the IBA Board of Directors and Henri de Romrée, Deputy CEO, assumes strategic and operational responsibility for all Group activities. Catherine...
► Artikel lesen
10.06.IBA SA: IBA Announces Research Collaboration to Strengthen Evidence on the Value of Proton Therapy1.011Louvain-la-Neuve, Belgium, June 10, 2026 - IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the leading provider of proton therapy solutions for...
► Artikel lesen
08.06.IBA SA: IBA signs contract with a major U.S. academic medical center to install two ProteusONE proton therapy solutions23
01.06.IBA SA: IBA launches Cyclone iKure, a cyclotron designed for industrial scale Astatine-211 production454Louvain-la-Neuve, Belgium - 01 June 2026 - IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the leading provider of radiopharmaceutical production...
► Artikel lesen
21.05.IBA SA: First quarter 2026 update: starting the year on track, with product innovation progress773Louvain-la-Neuve, Belgium, 21 May 2026 - IBA (Ion Beam Applications S.A), the world leader in particle accelerator technology, shares its business update for the first quarter of 2026. Group Overview...
► Artikel lesen
20.05.IBA SA: IBA launches Rhodotron LITE, a new low-power X-ray accelerator expanding access to sustainable irradiation solutions3
13.05.IBA SA: IBA introduces AdaPTinsight XR, the next generation of CBCT imaging for image-guided proton therapy6
1 2 Weiter >>
31 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1